Of particular interest in developing therapeutics to promote neural repair, a number of groups have validated the feasibility of ectopic TF expression in preclinical models of injury and disease, including Alzheimer’s disease [40], Parkinson’s disease [41], and stroke [26,42]. This evidence concerns the gene TF and Stroke.